Evoke Pharma NASDAQ EVOK
$0.48 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.60M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.87M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.12
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

3.34M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-54.30 %
Upcoming events Evoke Pharma All events
No upcoming events scheduled

Stock chart Evoke Pharma

Stock analysis Evoke Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.20 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.62 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
- 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
- 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
310.27 8.90

Price change Evoke Pharma per year

0.96$ 5.00$
Min Max

Summary analysis Evoke Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Evoke Pharma

Revenue and net income Evoke Pharma

All parameters

About company Evoke Pharma

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Address:
420 Stevens Avenue, Solana Beach, CA, United States, 92075
Company name: Evoke Pharma
Issuer ticker: EVOK
ISIN: US30049G1040
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2013-09-25
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.evokepharma.com

On which stock exchange are Evoke Pharma (EVOK) stocks traded?

Evoke Pharma (EVOK) stocks are traded on NASDAQ.

What is the ticker of Evoke Pharma stocks (EVOK)?

The stock ticker of Evoke Pharma’s stocks or in other words, the code is EVOK. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Evoke Pharma (EVOK) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Evoke Pharma (EVOK) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Evoke Pharma (EVOK) stocks traded?

Evoke Pharma (EVOK) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Evoke Pharma (EVOK) stocks today?

The current price of Evoke Pharma stocks on 03.05.2024 is 0.48 dollars. per share.

What is the dynamics of Evoke Pharma (EVOK) stocks from the beginning of the year?

Evoke Pharma (EVOK) quotes have increased by -53.4% from the beginning of the year up to 0.48 dollars. per 1 stocks.

How much did Evoke Pharma (EVOK) stocks increase in мае 2024?

This month Evoke Pharma (EVOK) quotes have increased by 0% to 0.48 dollars. per share.

How much are Evoke Pharma (EVOK) stocks worth?

Today, on October, 03.05.2024 Evoke Pharma’s (EVOK) stocks cost 0.48 dollars..

What is the market capitalization of Evoke Pharma (EVOK)?

Capitalization is the market value of Evoke Pharma (EVOK) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 03.05.2024, the market capitalization of Evoke Pharma (EVOK) is estimated at about 1604674 dollars.